In recent years there has been an increased acceptance of the cochlear implant as an appropriate sensory aid for selected hearing-impaired individuals with profound losses. With the Food and Drug Administration's release of the 3M/House single channel cochlear implant on November 29, 1984 and the Nucleus 22- channel cochlear implant on October 31, 1985 it is anticipated that many new groups of otologists and audiologists will have direct involvement in this exciting new approach to the management of patients with profound hearing impairments. This report reviews our cochlear implant selection protocol for the severe to profound adult hearing-impaired population.
ASJC Scopus subject areas
- Speech and Hearing